
USFDA APPLICATION NUMBER - 22525 / DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 7MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| MEMANTINE HYDROCHLORIDE(UNII: JY0WD0UA60) (memantine - UNII:W8O17SJF3T) | MEMANTINE HYDROCHLORIDE | 7mg |
Inactive Ingredients
| Ingredient Name | Apotex Corp | Avera McKennan Hospital |
|---|---|---|
| AMMONIA(5138Q19F1X) | ||
| ETHYLCELLULOSE (100 MPA.S)(47MLB0F1MV) | ||
| GELATIN(2G86QN327L) | ||
| hypromellose 2910 (15 MPA.S)(36SFW2JZ0W) | ||
| MEDIUM-CHAIN TRIGLYCERIDES(C9H2L21V7U) | ||
| OLEIC ACID(2UMI9U37CP) | ||
| POLYETHYLENE GLYCOL 400(B697894SGQ) | ||
| POLYETHYLENE GLYCOL 8000(Q662QK8M3B) | ||
| POVIDONE K30(U725QWY32X) | ||
| SUCROSE(C151H8M554) | ||
| TALC(7SEV7J4R1U) |